Tolbutamide Sodium

CHEMBL1200874 Phase 4 ได้รับการอนุมัติ Small molecule
Half-Life
—
Bioavailability
—
Protein Binding
—
Molecular Weight
292.3 g/mol
LogP
—
Phase
4

A sodium salt form of tolbutamide with the same therapeutic properties. This oral sulfonylurea medication stimulates the pancreas to produce more insulin and is used to lower blood sugar in adults with type 2 diabetes.

น้ำหนักโมเลกุล

292.3300 g/mol

TPSA

72.60 Ų

ด้านการรักษา

Pharmacokinetics (PK)

Pharmacodynamics (PD)

โครงสร้าง 2 มิติ

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CCCCNC(=O)[N-]S(=O)(=O)c1ccc(C)cc1.[Na+]

InChI

InChI=1S/C12H18N2O3S.Na/c1-3-4-9-13-12(15)14-18(16,17)11-7-5-10(2)6-8-11;/h5-8H,3-4,9H2,1-2H3,(H2,13,14,15);/q;+1/p-1

Molecular Formula

C12H17N2NaO3S

HBD / HBA

1 / 4

พันธะที่หมุนได้

5

อะตอมหนัก

19

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

คำถามที่พบบ่อย

A sodium salt form of tolbutamide with the same therapeutic properties. This oral sulfonylurea medication stimulates the pancreas to produce more insulin and is used to lower blood sugar in adults with type 2 diabetes.

Yes, Tolbutamide Sodium is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200874. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 23690448. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

ข้อจำกัดความรับผิดชอบทางการแพทย์

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.